ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,059 | +44.9% | 3,760 | +64.1% | 0.00% | – |
| Q2 2023 | $70,425 | -64.7% | 2,291 | -58.6% | 0.00% | – |
| Q1 2023 | $199,570 | +16.0% | 5,539 | +27.2% | 0.00% | – |
| Q4 2022 | $172,110 | -14.4% | 4,355 | -12.6% | 0.00% | – |
| Q3 2022 | $201,000 | -59.7% | 4,981 | -58.0% | 0.00% | -100.0% |
| Q2 2022 | $499,000 | +15.2% | 11,870 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $433,000 | +44.8% | 11,105 | +48.1% | 0.00% | – |
| Q4 2021 | $299,000 | +686.8% | 7,497 | +707.9% | 0.00% | – |
| Q2 2021 | $38,000 | -2.6% | 928 | +2.5% | 0.00% | – |
| Q1 2021 | $39,000 | -13.3% | 905 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +18.4% | 905 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -13.6% | 905 | 0.0% | 0.00% | – |
| Q2 2020 | $44,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |